Biotech Values

[Bio_pete]

My favorite is ISIS. Its gotten beaten down due to an overreaction on the MIPO trial results & a 4 month extension to the original timeline for filing for an NDA. Investors run for the exits when there's any mention of elevated liver enzymes, but the experts were not overly concerned.

ISIS is getting closer to oral delivery of their drugs which should attract more investors & possible buy-out rumors.

Their bringing a Factor XI antithrombotic into the clinic this year so maybe some of the investors on this board will have to start following the stock.

5 Biotechs under $5
http://www.dailyfinance.com/story/investing/investing-in-2010-five-biotechs-under-5/19293591/